Newsletter

9/25/2014

On September 24, 2014 in an 8K filed on the SEC’s EDGAR site, the company announced that the Imaging3 Board of Directors has appointed Richard J. Klug and William T.C. Lu to the Imaging3 Board of Directors, effective immediately. Mr. Klug serves as Senior Region Manager for Sharp Electronics Corp., Mahwah, NJ, responsible for technical and organizational support of all Sharp products in a six-state Pacific NW Region. He has been with Sharp Electronics Corp. since 1997. Mr. Lu serves as Chief Executive Officer of Saigon National Bank in Westminster, California, responsible for overseeing the operations of the bank, start-up organizational activities, and serving as the bank’s regulatory liaison. He has held this position since 2009.

The 8k can be viewed on the SEC’s EDGAR website, www.sec.gov.

If you have any questions or would like to discuss the future of the company please feel free to contact me via email or by phone.

Sincerely,

Dane Medley, Chairman/CEO
Imaging3, Inc
3200 W. Valhalla Drive
Burbank, CA 91505
(800)900-9729 ext 113
(818)260-0445 Fax
Email: dane@imaging3.com
http://www.imaging3.com

CONFIDENTIALITY NOTICE: This email message, together with any documents, files and/or email messages attached to it, is intended for the sole use of the individual or entity to whom it is addressed, and may contain information that is legally privileged, confidential and restricted from disclosure. If you are not the intended recipient, or responsible for delivery to that person, you are hereby notified that any dissemination or copying of this communication is STRICTLY PROHIBITED. In such case please notify the sender by reply email and delete this message without reading, printing or saving.

SAFE HARBOR STATEMENT: Matters discussed in this newsletter contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this newsletter, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company.